A ‘brain training’ app could help people who suffer from obsessive compulsive disorder (OCD) manage their symptoms, which may typically include excessive handwashing and contamination fears.
In a study published Read more
Only a small proportion of cases of dementia are thought to be inherited – the cause of the vast majority is unknown. Now, in a study published today in the journal Nature Communications, Read more
People at high risk of a heart attack in adulthood could be spotted much earlier in life with a one-off DNA test, according to new research part-funded by the British Heart Foundation and Read more
NIHR-funded researcher Professor Roman Hovorka has been nominated for the Groundbreaking Pioneer or Discovery category of The Sun’s Who Cares Wins health awards for his research developing an artificial pancreas for people with Read more
The country’s top mental health researchers and clinicians are joining forces to solve some of the greatest mental health challenges facing the UK public.
The group of investigators, based in leading universities and Read more
Patterns of genetic mutation in ovarian cancer are helping make sense of the disease and could be used to personalise treatment in future, according to a study published in Nature Genetics.
Researchers from Read more
New research published in the Lancet and funded and supported by the National Institute for Health Research (NIHR) has come to important conclusions about screening women for abdominal aortic aneurysms (AAAs).
The NHS Read more
Baby’s sex affects the mother’s metabolism and may influence the risk of pregnancy-related complications
The sex of a baby controls the level of small molecules known as metabolites in the pregnant mother’s blood, which may explain why risks of some diseases in pregnancy vary depending whether the Read more
Six months of Herceptin could be as effective as 12 months for some women with HER2 positive breast cancer
For women with HER2 positive early-stage breast cancer taking Herceptin for six months could be as effective as 12 months in preventing relapse and death, and can reduce side effects, finds new research.